STOK · NASDAQ · Biotechnology

Stoke Therapeutics

Develops antisense medicines that restore protein expression in severe genetic diseases.

$31.62
After-hours close+0.01 (+0.03%)
At close$31.61(−3.01%)
DateEstimateReportedSurprise
Nov 2026−$0.88
Aug 2026−$0.80−$0.93−17.0%
May 2026−$0.80−$0.79+1.3%
Mar 2026−$0.75−$0.97−29.3%
Nov 2025−$0.54−$0.65−20.4%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Feb 2020
Nov 2019
Aug 2019
Jun 2019
Mar 2019
Sep 2018
Jun 2018
Mar 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 3, 2026−$0.88$8.2M
Aug 3, 2026−$0.80−$0.93−17.0%$4.9M$9.3M+90.7%
May 7, 2026−$0.80−$0.79+1.3%$6.5M$6.2M−3.9%
Mar 16, 2026−$0.75−$0.97−29.3%$5.8M$1.4M−76.0%
Nov 4, 2025−$0.54−$0.65−20.4%$4.6M$10.6M+133.4%

The latest year is open to everyone — the 30 quarters behind it read with an account.

Sign in
Aug 12, 2025
May 13, 2025
Mar 18, 2025
Nov 5, 2024
Aug 7, 2024
May 6, 2024
Mar 25, 2024
Nov 7, 2023
Aug 7, 2023
May 4, 2023
Mar 6, 2023
Nov 14, 2022
Aug 8, 2022
May 10, 2022
Mar 10, 2022
Nov 8, 2021
Aug 10, 2021
May 10, 2021
Mar 9, 2021
Nov 12, 2020
Aug 10, 2020
May 15, 2020
Feb 24, 2020
Nov 12, 2019
Aug 14, 2019
Jun 19, 2019
Mar 31, 2019
Sep 30, 2018
Jun 30, 2018
Mar 31, 2018